$20.48
0.452.25%
al cierre: -
$20.40
-0.08-0.38%
After hour: Oct 31, 7:54 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Teva Pharmaceutical Indus informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 5
Estimación de BPA
$0.670
Estimación de ingresos trimestrales
$4.34B
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$16.63B
Analice el historial de beneficios de Teva Pharmaceutical Indus utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA | Teva Pharmaceutical Indus | $0.71 | $0.70 | — | — | $4.23B | $4.43B | — | — | 01/28/2026 | |
TEVA | Teva Pharmaceutical Indus | $0.69 | $0.67 | — | — | $4.33B | $4.34B | — | — | 11/05/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.61 | $0.61 | $0.66 | 8.20% | $4.16B | $4.28B | $4.20B | -1.83% | 07/30/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.48 | $0.46 | $0.52 | 13.04% | $3.82B | $3.99B | $3.89B | -2.48% | 05/07/2025 | |
TEVA | Teva Pharmaceutical Indus | $1.00 | $0.70 | $0.71 | 1.43% | $4.46B | $4.12B | $4.23B | 2.65% | 01/29/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.60 | $0.66 | $0.69 | 4.55% | $3.85B | $4.12B | $4.33B | 5.15% | 11/06/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.56 | $0.55 | $0.61 | 10.91% | $3.88B | $4.06B | $4.16B | 2.56% | 07/31/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.40 | $0.51 | $0.48 | -5.88% | $3.66B | $3.73B | $3.82B | 2.39% | 05/08/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.71 | $0.77 | $1.00 | 29.87% | $3.88B | $4.01B | $4.46B | 11.15% | 01/31/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.61 | $0.60 | -1.64% | $3.60B | $3.72B | $3.85B | 3.49% | 11/08/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.68 | $0.52 | $0.56 | 7.69% | $3.79B | $3.71B | $3.88B | 4.53% | 08/02/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.55 | $0.56 | $0.40 | -28.57% | $3.66B | $3.63B | $3.66B | 0.85% | 05/10/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.77 | $0.71 | $0.71 | 0.00% | $4.10B | $3.93B | $3.88B | -1.17% | 02/08/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.62 | $0.59 | -4.84% | $3.89B | $3.83B | $3.60B | -6.14% | 11/03/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.57 | $0.68 | 19.30% | $3.91B | $3.78B | $3.79B | 0.16% | 07/26/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.63 | $0.55 | $0.55 | 0.00% | $3.98B | $3.75B | $3.66B | -2.37% | 05/03/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.68 | $0.73 | $0.77 | 5.48% | $4.45B | $4.29B | $4.10B | -4.43% | 02/09/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.58 | $0.65 | $0.59 | -9.23% | $3.98B | $4.03B | $3.89B | -3.55% | 10/27/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.55 | $0.59 | $0.59 | 0.00% | $3.87B | $4.04B | $3.91B | -3.22% | 07/28/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.76 | $0.59 | $0.63 | 6.78% | $4.36B | $4.02B | $3.98B | -0.95% | 04/28/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.62 | $0.63 | $0.68 | 7.94% | $4.47B | $4.37B | $4.45B | 1.92% | 02/10/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.58 | $0.58 | $0.58 | 0.00% | $4.26B | $4.07B | $3.98B | -2.26% | 11/05/2020 |
Teva Pharmaceutical Indus (TEVA) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-30 | $0.66 | $0.61 | 8.20 % |
| Q1 | 2025-05-07 | $0.52 | $0.46 | 13.0 % |
| Q4 | 2025-01-29 | $0.71 | $0.70 | 1.43 % |
| Q3 | 2024-11-06 | $0.69 | $0.66 | 4.55 % |
Teva Pharmaceutical Indus (TEVA) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-30 | $4.20B | $4.28B | -1.83 % |
| Q1 | 2025-05-07 | $3.89B | $3.99B | -2.48 % |
| Q4 | 2025-01-29 | $4.23B | $4.12B | 2.65 % |
| Q3 | 2024-11-06 | $4.33B | $4.12B | 5.15 % |
PREGUNTAS FRECUENTES
¿Cuándo Teva Pharmaceutical Indus (NYSE:TEVA) publicará los resultados?
Está previsto que Teva Pharmaceutical Indus (TEVA) presente resultados el enero 28, 2026. Los últimos resultados se publicaron el julio 30, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Teva Pharmaceutical Indus (NYSE:TEVA)?
El BPA real fue de $0.66, que superó la estimación de $0.61.
¿Cuáles fueron los ingresos de Teva Pharmaceutical Indus (NYSE:TEVA)?
Los ingresos reales fueron $4.2B, que no alcanzó la estimación de $4.3B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.